Vyvanse (lisdexamfetamine) and Focalin (dexmethylphenidate) are both stimulant ADHD medicines, but they come from the two different stimulant families: Vyvanse is an amphetamine and Focalin is a methylphenidate. Vyvanse is a “prodrug” that the body slowly converts into active dextroamphetamine. It lasts about 13 hours in children and 14 hours in adults from one morning capsule. Focalin is the more active half of methylphenidate (the drug in Ritalin), so it works at half the dose. It comes as a short-acting tablet taken twice a day (Focalin) or a once-daily capsule lasting about 12 hours (Focalin XR). Neither is clearly better for everyone. Large analyses favour methylphenidate as the first choice in children and amphetamines in adults, and people who don’t do well on one family often do well on the other. Only Vyvanse is also approved for binge eating disorder.
This guide compares how they work, how long they last, dosing, side effects, misuse risk, switching, and taking them together, from the FDA prescribing information and comparative research.
This is general information, not medical advice. Both are Schedule II controlled substances. Changes should be made with your prescriber.
Vyvanse vs Focalin at a glance
| Vyvanse (lisdexamfetamine) | Focalin / Focalin XR (dexmethylphenidate) | |
|---|---|---|
| Stimulant family | Amphetamine | Methylphenidate |
| How it becomes active | Inactive prodrug converted to dextroamphetamine in the blood | Active as soon as it’s absorbed |
| Approved for | ADHD (age 6 and up); moderate to severe binge eating disorder (adults) | ADHD (age 6 and up) |
| Starts working | About 1.5 to 2 hours | About 30 to 60 minutes |
| Lasts | About 13 hours (children) to 14 hours (adults) | Tablet: about 4 to 6 hours; XR: about 12 hours |
| Doses per day | One | Tablet: two; XR: one |
| Usual dose range | 30 to 70 mg | Tablet: 5 to 20 mg/day; XR: 5 to 30 mg (children), 10 to 40 mg (adults) |
| Forms | Capsule (can be opened and mixed with water, juice or yogurt), chewable tablet | Tablet; XR capsule (can be sprinkled on applesauce) |
| Controlled substance | Schedule II | Schedule II |
| Generic | Yes (lisdexamfetamine) | Yes (dexmethylphenidate and dexmethylphenidate ER) |
Which is stronger or works better?
There are no large trials comparing Vyvanse with Focalin directly, so the best evidence comes from comparing the two families. The 2018 Lancet Psychiatry network meta-analysis by Cortese and colleagues, which pooled 133 trials, concluded that:
- In children and adolescents, methylphenidate was the preferred first choice. Amphetamines were slightly more effective on clinician ratings, but methylphenidate was better tolerated overall.
- In adults, amphetamines were the preferred first choice, with the largest effect and good acceptability.
“Stronger” also depends on dose. Milligram numbers can’t be compared across families: 20 mg of Focalin XR and 50 mg of Vyvanse can be roughly similar in effect. The most useful finding from clinical practice is that response is individual. Many people who get side effects or a weak response on one family do well on the other, which is why guidelines suggest trying both stimulant families before concluding that stimulants don’t work.
How each one works
Vyvanse: a built-in slow release
Lisdexamfetamine is dextroamphetamine bonded to the amino acid lysine. In that form it does nothing. After absorption, enzymes in red blood cells gradually cut the lysine off, releasing active dextroamphetamine. That conversion step sets the pace, so blood levels rise smoothly (peaking about 3.5 to 5 hours after the dose) and fade slowly. The capsule itself has no special release coating. The long action comes from the chemistry, which is why the capsule can be opened and dissolved in a drink without losing its duration.
Once released, dextroamphetamine increases dopamine and norepinephrine in two ways: it blocks their reuptake and pushes more of them out of nerve endings.
Focalin: the active half of Ritalin
Ordinary methylphenidate (Ritalin, Concerta) is a 50:50 mix of two mirror-image forms. Nearly all the therapeutic effect comes from one of them, the d-form (dexmethylphenidate). Focalin contains only that form, so a Focalin dose is half the equivalent Ritalin dose: 10 mg of Focalin is roughly 20 mg of Ritalin. Methylphenidate blocks dopamine and norepinephrine reuptake but doesn’t push extra out the way amphetamines do, a mechanical difference that may explain why some people tolerate one family better than the other.
Focalin XR uses beads: half release immediately, and half release about four hours later. That copies two tablet doses taken four hours apart and gives roughly 12 hours of coverage.
How long each one lasts in a real day

| Starts | Peak effect | Wears off (morning dose) | |
|---|---|---|---|
| Vyvanse | About 1.5 to 2 hours | Mid-morning to early afternoon | Early evening (about 13 to 14 hours) |
| Focalin XR | About 30 to 60 minutes | Two peaks: about 1.5 hours and about 6.5 hours | Early evening (about 12 hours) |
| Focalin tablet | About 30 minutes | About 1 to 1.5 hours | About 4 to 6 hours; a second dose is needed |
Vyvanse’s slower start is a common complaint: some people feel little for the first hour or two, which can clash with an early school bus or a 7 a.m. shift. Focalin XR starts faster. Some prescribers pair Vyvanse with a small morning dose of a short-acting stimulant for that early gap, or add a short-acting afternoon dose to either for homework or evening work.
What about Foquest?
Foquest, which people often search alongside Vyvanse, is a Canadian long-acting methylphenidate. It’s ordinary methylphenidate (both forms), not dexmethylphenidate. Health Canada’s product monograph reports an onset within 1 hour and a duration of about 13 hours in children and 16 hours in adults, the longest of the methylphenidate products. For Canadians weighing a long-acting methylphenidate against Vyvanse, Foquest is the closer match to Vyvanse’s all-day coverage than Focalin XR is. Foquest is not sold in the US.
Dosing compared
| Starting dose | How it’s increased | Maximum | |
|---|---|---|---|
| Vyvanse, ADHD (age 6+) | 30 mg each morning | 10 or 20 mg about weekly | 70 mg/day |
| Vyvanse, binge eating disorder (adults) | 30 mg each morning | 20 mg weekly toward 50 to 70 mg | 70 mg/day |
| Focalin tablet (new to methylphenidate) | 2.5 mg twice daily, at least 4 hours apart | 2.5 to 5 mg weekly | 20 mg/day |
| Focalin XR, children | 5 mg each morning | 5 mg weekly | 30 mg/day |
| Focalin XR, adults | 10 mg each morning | 10 mg weekly | 40 mg/day |
| Switching from Ritalin-type methylphenidate to Focalin | Half the current methylphenidate dose | Adjust to response | As above |
Side effects compared
Both share the usual stimulant side effects: reduced appetite, trouble sleeping, dry mouth, headache, stomach ache, irritability, and small rises in heart rate and blood pressure. Differences people commonly notice:
- Appetite and weight: amphetamines, including Vyvanse, tend to suppress appetite more strongly, and the long duration can mean lunch and an afternoon snack get skipped. In the Cortese analysis, amphetamines also caused more weight loss in children.
- Sleep: Vyvanse’s 13 to 14 hour tail can keep some people awake if taken after about 8 a.m. Focalin tablets, which wear off sooner, give more control over evening timing.
- Comedown: Vyvanse’s smooth decline usually means a gentler wear-off. Short-acting Focalin can produce more noticeable dips and rebound irritability between doses.
- Heart rate and blood pressure: in children, the Cortese analysis found amphetamines raised diastolic blood pressure more than methylphenidate. Both need blood pressure and pulse checks.
- Tics, anxiety and mood: either can worsen anxiety or tics in some people. Switching families sometimes helps, and response is individual.
- Growth: both can slow height and weight gain in children, so growth is tracked at each visit.
Rare but serious risks apply to both: heart problems in people with underlying heart disease, new psychotic or manic symptoms, poor circulation in fingers and toes (Raynaud’s phenomenon), and, with methylphenidate, rare prolonged erections (priapism).
Misuse risk and the prodrug question
Both carry the FDA’s boxed warning for abuse, misuse and addiction, and both are Schedule II. Vyvanse’s prodrug design gives it one real advantage. Because the conversion happens in the blood, snorting or injecting it doesn’t produce the rapid rush that misusing an already-active stimulant does, and studies of drug-liking in people with stimulant misuse histories showed lower “liking” scores at therapeutic doses. That reduces the appeal for non-oral misuse. It does not prevent misuse by mouth, dependence, or diversion (giving or selling pills to others). Focalin, especially the immediate-release tablet, has no such barrier. Store either one locked away, and count tablets if teenagers or visitors are in the home.
Binge eating disorder
In 2015, Vyvanse became the first medicine FDA-approved for moderate to severe binge eating disorder in adults, based on two 11-week trials measuring fewer binge days per week. The label states clearly that it is not approved or recommended for weight loss, and that other stimulants used for weight loss have been linked to serious heart problems. Focalin has no binge eating approval. For someone with both ADHD and binge eating disorder, Vyvanse can address both with one medicine.
Switching between Vyvanse and Focalin
There is no official conversion table between the two families. Prescribers usually stop one and start the other at a moderate dose the next morning, then adjust weekly. Stimulants clear within a day, so long overlaps aren’t needed. Common reasons to switch include:
- Too slow a start or too long a tail on Vyvanse, which favours Focalin XR.
- Wearing off too early or uneven coverage on Focalin, which favours Vyvanse.
- Side effects on one family, such as appetite loss, irritability or anxiety, which suggest trying the other.
- Insurance or stimulant shortages, which have hit both drugs at times.
Can Vyvanse and Focalin be taken together?
Sometimes, but it isn’t routine. The usual pattern is a long-acting stimulant in the morning plus a small short-acting “booster” later in the day. Most prescribers use a booster from the same family (for example Vyvanse with a dextroamphetamine tablet, or Focalin XR with a Focalin tablet), but a Vyvanse plus short-acting Focalin combination is used when one family suits the morning and the other suits the afternoon. Combining two stimulants adds their effects on heart rate, blood pressure, sleep and appetite, and doubles the controlled-substance paperwork. It should only be done on a prescriber’s plan, never by taking a leftover prescription.
Interactions and practical cautions
- MAO inhibitors: both are contraindicated with MAOIs and within 14 days of stopping one.
- Acidifying and alkalinizing agents: vitamin C, fruit juices and urine acidifiers can lower amphetamine levels. Antacids and sodium bicarbonate can raise them. This affects Vyvanse, not Focalin.
- Antacids and acid reducers with Focalin XR: changes in stomach pH can alter the bead release pattern, so they’re used with caution.
- Decongestants and other stimulants: pseudoephedrine, caffeine in large amounts, and diet pills add to cardiovascular effects.
- Antidepressants: combining with SSRIs or SNRIs is common but carries a small serotonin syndrome risk with amphetamines. See our SSRI comparison tool.
- Alcohol: stimulants mask how drunk you feel, raising the risk of overdrinking. See methylphenidate and alcohol and our alcohol interaction checker.
Missed doses, late doses and medication breaks
- Missed morning dose: with Vyvanse or Focalin XR, take it if you remember within a couple of hours. If it’s already early afternoon, skip it rather than lose a night’s sleep. Never double the next day’s dose.
- Focalin tablets: if the midday dose is missed, take it only if it’s at least 4 to 5 hours before bedtime.
- Weekend or holiday breaks: because stimulants work and clear within a day, some families skip doses on non-school days to help appetite and growth. That’s a reasonable choice with either drug, but agree on it with the prescriber, and expect symptoms to return on those days.
- Shortages: both lisdexamfetamine and dexmethylphenidate have been affected by US stimulant shortages. If your pharmacy can’t fill the prescription, ask whether another strength (for example two 20 mg capsules instead of one 40 mg) or another pharmacy has stock. Switching drug or family needs a new prescription.
Pregnancy and breastfeeding
Data for both in pregnancy are mainly observational. Amphetamines can cause low birth weight and premature birth when misused, and newborns may show withdrawal symptoms. Whether to continue is a balance between the risks of untreated ADHD (driving, work, mental health) and those uncertainties, and should be discussed before conception if possible. Amphetamine passes into breast milk, and the Vyvanse label advises against breastfeeding. Methylphenidate passes into milk in small amounts, and decisions are individual.
Who each one might suit
| Situation | Often favours |
|---|---|
| Need for 13 to 14 hours of coverage from one dose | Vyvanse |
| ADHD plus binge eating disorder | Vyvanse |
| Concern about non-oral misuse in the household | Vyvanse |
| Can’t swallow capsules | Vyvanse (chewable or dissolved) or Focalin XR (sprinkled) |
| Child’s first stimulant | Methylphenidate family, such as Focalin XR, is the usual first choice |
| Needs quick morning onset | Focalin XR |
| Wants flexible, shorter coverage or evenings free of medicine | Focalin tablets |
| Did well on Ritalin or Concerta but had side effects | Focalin (same family, sometimes better tolerated) |
| Bad experience with methylphenidate | Vyvanse |
To compare these with other options, including non-stimulants, use our ADHD medication comparison tool. Related comparisons: Concerta vs Strattera, Mydayis vs Vyvanse, and Desoxyn vs Adderall.
Frequently asked questions
Is Focalin or Vyvanse stronger?
Neither is simply stronger. They belong to different stimulant families, and milligrams can’t be compared. Amphetamines like Vyvanse have a slightly larger average effect, especially in adults, while methylphenidate like Focalin is usually preferred first in children. Individual response matters more than averages.
Which lasts longer, Vyvanse or Focalin XR?
Vyvanse lasts a little longer: about 13 hours in children and 14 hours in adults, compared with about 12 hours for Focalin XR. Focalin tablets last only about 4 to 6 hours.
Can you take Vyvanse and Focalin together?
Some prescribers add a small short-acting Focalin dose to morning Vyvanse for afternoon coverage, but it isn’t routine and adds to cardiovascular and sleep effects. Only combine them on a prescriber’s plan.
Is Foquest the same as Focalin?
No. Foquest is a Canadian long-acting form of regular methylphenidate lasting up to about 16 hours in adults. Focalin is dexmethylphenidate, the more active half of methylphenidate.
Is Vyvanse harder to misuse than Focalin?
It’s less appealing to snort or inject, because it must be converted in the blood before it works. It can still be misused by mouth, and both carry the same boxed warning for abuse and addiction.
References
- Vyvanse (lisdexamfetamine dimesylate) prescribing information. Takeda. DailyMed.
- Focalin XR (dexmethylphenidate) extended-release capsules, prescribing information. Novartis. DailyMed.
- Focalin (dexmethylphenidate) tablets, prescribing information. Novartis. DailyMed.
- Cortese S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5:727-738.
- Foquest (methylphenidate hydrochloride controlled-release) product monograph. Health Canada.
- Lisdexamfetamine dimesylate (Vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder. P T. 2010.
- Heo YA, Duggan ST. Lisdexamfetamine: a review in binge eating disorder. CNS Drugs. 2017.
Try our interactive tool: ADHD medication comparison tool
Compare stimulants and non-stimulants by duration, ages and controlled status.
About this article
Written by the Health Linear Editorial Team from primary sources such as FDA prescribing information, DailyMed, NIH and peer-reviewed studies, which are linked in the article. Last updated October 28, 2026.
Read our editorial process and medical disclaimer. Spotted an error? Tell us and we will correct it.